enGene Therapeutics (ENGN) Amortizatization of Intangibles (2025 - 2026)
enGene Therapeutics (ENGN) posted quarterly Amortizatization of Intangibles of $494000.0 for Q2 2026, down 58.66% year-over-year from $1.2 million in Q2 2025, and down 16.41% quarter-over-quarter from $591000.0 in Q1 2026.
enGene Therapeutics (ENGN) Amortizatization of Intangibles (2025 - 2026) Analysis & Trends
enGene Therapeutics (ENGN) has reported Amortizatization of Intangibles for 2 consecutive years, with $494000.0 the latest figure, recorded in Q2 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | enGene Therapeutics | 124.11 Mn | 124.11 Mn | - | 494,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 494,000.00 |
| Apr 30, 2026 | 494,000.00 |
| Jan 31, 2026 | 591,000.00 |
| Jan 31, 2026 | 591,000.00 |
| Jul 31, 2025 | 668,000.00 |
| Jul 31, 2025 | 668,000.00 |
| Apr 30, 2025 | 1.20 Mn |
| Apr 30, 2025 | 1.20 Mn |
| Jan 31, 2025 | 782,000.00 |
| Jan 31, 2025 | 782,000.00 |